AtlasAI基础设施

Search documents
上市三月闪电叩开港股通!云知声医疗AI硬实力征服资本树立标杆
Sou Hu Cai Jing· 2025-09-10 14:53
资本信心的核心,离不开云知声构建的三层技术闭环。底层AtlasAI基础设施拥有184PFLOPS算力与10PB存储,为模型训练提供坚实底座;中层云知大脑以 600亿参数山海大模型为核心,其医疗版(UniGPT-Med-U1)在MedBench评测中斩获93.1分(医疗安全伦理单项104.9分),连续刷新全球医疗大模型纪录; 顶层应用方案则聚焦医疗与日常生活场景,形成"大模型-智能体-端侧优化"的AGI体系,实现"模型-数据-应用"的飞轮效应。 医疗场景成为技术落地的最佳试金石。在北京友谊医院顺义院区,云知声门诊病历生成系统通过麦克风阵列降噪技术,精准捕捉医患对话,经山海大模型处 理后自动生成结构化病历。数据显示,该系统使病历录入效率提升80%,医生问诊时间节省15%,单份病历采纳率高达98%,已覆盖肝病、心脏内科等6大科 室。更值得关注的是,系统能智能提取诊疗关键信息,辅助医生制定方案,推动AI从"辅助工具"升级为深度融入临床的"生产力工具"。 2025年9月8日,恒生指数公司季度调整生效首日,刚上市满三月的云知声(09678.HK)正式纳入恒生综合指数并跻身港股通。这一"闪电入通"事件,标志 着资本市场对其 ...
募资缩水六成!云知声引商汤为基石 初代AI“玩家”聚首
2 1 Shi Ji Jing Ji Bao Dao· 2025-06-22 06:16
Core Viewpoint - CloudWalk Technology is set to launch its IPO on the Hong Kong Stock Exchange, aiming to raise up to HKD 320 million, with SenseTime as a cornerstone investor, indicating a strategic partnership in the multimodal field [1][9]. Fundraising and Financials - The company plans to issue 1.561 million H-shares, with 90% allocated for international sales and 10% for Hong Kong sales, at a price range of HKD 165 to HKD 205 per share, potentially raising up to HKD 320 million [6][7]. - The fundraising amount has been significantly reduced by 65% compared to its previous plan for the Sci-Tech Innovation Board, reflecting a more conservative valuation strategy [7]. - Financial data shows that CloudWalk's revenue for 2022, 2023, and 2024 is projected to be HKD 600 million, HKD 727 million, and HKD 939 million respectively, with a compound annual growth rate of 23% [5][6]. Investment and Partnerships - SenseTime, along with other cornerstone investors, has committed to significant investments, with SenseTime's subsidiary subscribing for HKD 43.7 million worth of shares [9]. - The partnership with SenseTime will focus on collaborative innovation in voice and visual multimodal interactions, enhancing the user experience in various industries [9][10]. - The company has a strong shareholder base, including notable investors such as JD.com, 360, and Qualcomm, indicating robust backing for its business model [8]. Use of Proceeds - Approximately 45.6% of the raised funds will be allocated to enhancing R&D capabilities, while 47% will focus on expanding commercial opportunities, reflecting a balanced approach to growth [7][8]. - The company aims to improve existing solutions and penetrate new vertical industries, highlighting its commitment to commercial viability [7].